V1b receptor antagonist (HolsboerMaschmeyer)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameV1b receptor antagonist (HolsboerMaschmeyer)
Drug Alias NameHM-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasopressin V1b receptor antagonists
TargetsVasopressin V1b receptor
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHolsboermaschmeyer Neurochemie Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHolsboermaschmeyer Neurochemie Gmbh
Active IndicationsN/A
Inactive IndicationsDepression

Other Information

ATC CodeN/A
Related LinksN/A